Andere talen JCR Pharmaceuticals Co., Ltd.

Aandelen

4552

JP3701000006

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
797 ^JPY	+0,50%		+2,05%	-32,00%

21/03	US Fed renteverwachtingen katapulteren Japanse aandelen naar nieuwe piek van 52 weken	MT
19/03	JCR Pharmaceuticals Co, Ltd. Kondigt het bereiken van een mijlpaal aan bij het gebruik van J-Brain Cargo-technologie voor neurodegeneratieve ziekten in een onderzoekssamenwerking met Alexion	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak	21/03
JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion	21/03
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion	20/03
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion	19/03
JCR Pharmaceuticals Co., Ltd. Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion	19/03
JCR Pharmaceuticals Co., Ltd.(TSE:4552) dropped from FTSE All-World Index	18/03
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd	13/03
JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community	29/02
JCR Pharmaceuticals Co., Ltd. Announces Organizational and Personnel Changes	28/02
JCR Pharmaceuticals Research Presentations at WORLDSymposium 2024 Showcase JR-141 and Other Investigational Treatments for Lysosomal Storage Disorders	15/02
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders	14/02
JCR Pharmaceuticals Co., Ltd. Presents Clinical Data on J-Brain Cargo®? to Deliver Medicines Across the Blood-Brain Barrier	14/02
JCR Pharmaceuticals Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	09/02
JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024	25/01
JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration	21/12
JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® Technology	21/12
Asia Markets Remain Mixed as Investors Step Back Following Rally	21/12
Japanese Shares Slip Back into Red as Wall Street Ends Winning Streak Ahead of Key US Data	21/12
JCR Pharmaceuticals' Partner Takeda to Scrap Gene Therapy Collaboration	21/12
JCR Pharmaceuticals Co., Ltd. and Takeda Pharmaceutical Co., Ltd. Announces Discontinuation of Gene Therapy Collaboration	20/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen JCR Pharmaceuticals Co., Ltd.

Aandelen

4552

JP3701000006

Andere talen

Filters